Sun Pharma, Hetero recall drugs in US
Sun Pharma is recalling a generic drug indicated to raise blood pressure in adults while Hetero Labs is recalling a drug used to…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
US Pharma market
Sun Pharma recalls 34000 bottles of Diltiazem Hydrochloride extended-release capsules from US
The capsules which are used to treat angina, high blood pressure and some types of irregular heartbeats failed dissolution testing
Lupin launches Rufinamide Tablets USP in the US
Rufinamide is indicated for the treatment of the symptoms of Lennox-Gastaut Syndrome
Pricing pressures, regulatory scrutiny prevail in US generics pharma industry: ICRA
ICRA expects mid to high single-digit price erosion to continue to exert pressure over the near term, resulting in muted revenue…
Lupin launches Tavaborole Topical Solution in US
It is an oxaborole antifungal indicated for the topical treatment of onychomycosis of the toenails due to Trichophyton rubrum or…
Ocugen to apply for full US FDA approval of Covaxin, not for EUA
Ocugen said the decision was based on a recommendation from the US FDA, which also requested more information and data for full…
Dr Reddy’s recalls 2,980 bottles of Atorvastatin Calcium tablets in US
The drug is prescribed to lower cholesterol, lower the risk of heart attack and stroke in patients with cardiovascular diseases,…
Dr Reddy’s launches Ertapenem for Injection in US
Dr Reddy’s Ertapenem for Injection, 1 g/vial, is available in packs of 10 vials per carton
Dr Reddy’s launches of AlbendazoleTablets, USP in the US market
Albendazole is an anthelmintic drug to treat parenchymal neurocysticercosis and cystic hydatid disease of the liver, lung, and…
Lupin, Sun Pharma, Jubilant Cadista recall generic medicines in US
Lupin is recalling 17,814 bottles of Cefprozil, Sun Pharma is recalling 13,834 bottles of Riomet and Jubilant Cadista…